Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain
Unknown statusNot applicableNCT05771103
View the official record on ClinicalTrials.gov Recruiting status changes often. Contact the study team listed on ClinicalTrials.gov, and talk to your doctor before joining a study.
This study has no listed site in Canada in this snapshot. It is included as part of the worldwide chronic pain corpus.
Brief summary (from the registry)
* Group A: SGB with alcohol injection by ultrasound guidance and C7 level confirmation by fluoroscopy. * Group B: Thermal RF; thermal RF neurolysis will be applied with a time of 60 seconds at 80º C, and then will be repeated twice . Stellate ganglion RF therapy will be done under fluoroscopy, integrated by ultrasound guidance
Study details
- Official title
- Stellate Ganglion Destruction With Alcohol Versus Thermal Ablation for Chronic Post Mastectomy Pain
- Conditions
- Post-mastectomy Pain Syndrome
- Interventions
- Device: thermal Radiofrequency neurolysis of Stellate ganglion
- Sponsor
- National Cancer Institute, Egypt
- Start date
- 2023-01-01
- Primary completion
- 2023-07-30
- Sex
- Female
- Age range
- from 20 Years to 65 Years
- Healthy volunteers
- true
- Results posted
- No results posted in this snapshot
- Countries
- Egypt
- Total sites listed
- 1
Eligibility criteria
Show eligibility criteria (verbatim from the registry)
Inclusion Criteria: * Female patient 20-65yrs underwent surgery for breast cancer * Pain duration of more than 6 months * Pain is moderate to severe pain (visual analog scale \[VAS\] ≥ 4 cm), * Pain described as a refractory one that is defined as pain for which classic biomedical therapy has proven ineffective * Pain is of positive neuropathic character as detected by the grading system for neuropathic pain (GSNP), with a score of 3 or 4 Exclusion Criteria: * Refusal of the patient * Recent myocardial infarction * Anti-coagulated patients or coagulopathy (evaluate risk/benefit ratio) * Glaucoma * Pre-existing counter lateral nerve palsy * Severe emphysema * Cardiac conduction block * Local and systemic sepsis * Local anatomical distortion (which may render the block technically difficult or hazardous. * Psychiatric illness.
Source: ClinicalTrials.gov (US National Library of Medicine), snapshot October 2026. Check the registry for current recruiting status. Record: https://clinicaltrials.gov/study/NCT05771103